How Kolkata workshop aims to boost pharmaceutical testing and compliance

The interactive session at the Central Drug Laboratory in Kolkata was designed to foster collaboration between regulatory bodies, testing facilities and the Indian Pharmacopoeia Commission. Delegates explored practical ways to improve method verification, quality assurance protocols and regulatory reporting for drug manufacturers across the country.

Key topics included the integration of the newly issued nitrosamine reference standards into routine assay procedures, the adoption of risk‑based sampling strategies, and the use of modern analytical techniques such as LC‑MS/MS for impurity profiling. Participants also discussed the importance of training laboratory personnel and updating standard operating procedures to reflect the latest scientific evidence.

By creating a platform for open dialogue, the workshop sought to bridge gaps between policy makers and industry, ensuring that the Indian pharmacopoeial standards remain robust and internationally competitive. The outcomes are expected to feed directly into the IPC 2026 strategic plan, reinforcing a culture of continuous improvement in pharmaceutical quality.